Emotional well-being in children and adolescents treated with atomoxetine for attention-deficit/hyperactivity disorder: Findings from a patient, parent and physician perspective using items from the pediatric adverse event rating scale (PAERS)

BACKGROUND: The objective of this analysis was to measure changes in items on the Pediatric Adverse Event Rating Scale (PAERS) that relate to emotional well-being of children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) during treatment with atomoxetine for up to 24 weeks fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Wehmeier, Peter M, Schacht, Alexander, Lehmann, Martin, Dittmann, Ralf W, Silva, Susan G, March, John S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430545/
https://www.ncbi.nlm.nih.gov/pubmed/18507848
http://dx.doi.org/10.1186/1753-2000-2-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430545/
https://www.ncbi.nlm.nih.gov/pubmed/18507848
http://dx.doi.org/10.1186/1753-2000-2-11

Ejemplares similares